Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Perampaladas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Hemorheology and Microcirculation|August 3, 2010
The impact of rosiglitazone on nitric oxide bioavailability and endothelial functionKumar Perampaladas, John D Parker, Tommaso Gori
Journal of Cardiovascular Pharmacology and Therapeutics|November 5, 2011
Rosiglitazone causes endothelial dysfunction in humansKumar Perampaladas, Tommaso Gori, John D Parker
BMJ (Clinical Research Ed.)|August 9, 2012
Raising the bar for market authorisation of new drugsHuseyin Naci, Jonathan Cylus, Sotiris Vandoros, et al.
The Lancet. Oncology|February 13, 2013
NICE guidance on vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanomaKumar Perampaladas, Nicola Hay, Fiona Rinaldi, et al.
Nature Biotechnology|August 11, 2010
Case study: India's billion dollar biotechJustin Chakma, Hassan Masum, Kumar Perampaladas, et al.
Globalization and Health|April 22, 2011
Indian vaccine innovation: the case of Shantha BiotechnicsJustin Chakma, Hassan Masum, Kumar Perampaladas, et al.
Annals of Emergency Medicine|February 15, 2011
Systematic review and meta-analysis of the effect of warming local anesthetics on injection painMary-Ellen Hogan, Sondra vanderVaart, Kumar Perampaladas, et al.
BMC International Health and Human Rights|December 15, 2010
The road to commercialization in Africa: lessons from developing the sickle-cell drug NiprisanKumar Perampaladas, Hassan Masum, Andrew Kapoor, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Hemorheology and Microcirculation|August 3, 2010
The impact of rosiglitazone on nitric oxide bioavailability and endothelial functionKumar Perampaladas, John D Parker, Tommaso Gori
Journal of Cardiovascular Pharmacology and Therapeutics|November 5, 2011
Rosiglitazone causes endothelial dysfunction in humansKumar Perampaladas, Tommaso Gori, John D Parker
BMJ (Clinical Research Ed.)|August 9, 2012
Raising the bar for market authorisation of new drugsHuseyin Naci, Jonathan Cylus, Sotiris Vandoros, et al.
The Lancet. Oncology|February 13, 2013
NICE guidance on vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanomaKumar Perampaladas, Nicola Hay, Fiona Rinaldi, et al.
Nature Biotechnology|August 11, 2010
Case study: India's billion dollar biotechJustin Chakma, Hassan Masum, Kumar Perampaladas, et al.
Globalization and Health|April 22, 2011
Indian vaccine innovation: the case of Shantha BiotechnicsJustin Chakma, Hassan Masum, Kumar Perampaladas, et al.
Annals of Emergency Medicine|February 15, 2011
Systematic review and meta-analysis of the effect of warming local anesthetics on injection painMary-Ellen Hogan, Sondra vanderVaart, Kumar Perampaladas, et al.
BMC International Health and Human Rights|December 15, 2010
The road to commercialization in Africa: lessons from developing the sickle-cell drug NiprisanKumar Perampaladas, Hassan Masum, Andrew Kapoor, et al.
Pageof 1